Skip to main content
. Author manuscript; available in PMC: 2013 Mar 25.
Published in final edited form as: J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):266–271. doi: 10.1097/QAI.0b013e318189a753

FIGURE 2.

FIGURE 2

HRs for the risk of detection of 3TC, PI, NNRTI, and NRTI resistance mutations in multivariable models adjusted for baseline demographics, pVL, and CD4 count. Stratified adherence levels of (1) <95% with 0 or 1 normal drug levels, (2) <95% with 2 normal drug levels, and (3) ≥95% with 0 or 1 normal drug levels were compared with the (4) ≥95% with 2 normal drug levels (HR 1.0). Results are reported as HRs (bars) with 95% CIs (lines).